# CAR-T Cells for HIV Infection

> **NCT04648046** · PHASE1,PHASE2 · RECRUITING · sponsor: **Steven Deeks** · enrollment: 18 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Cyclophosphamide
- **BIOLOGICAL:** LVgp120duoCAR-T cells, low dose
- **BIOLOGICAL:** LVgp120duoCAR-T cells, high dose
- **OTHER:** Analytic Treatment Interruption

## Key facts

- **NCT ID:** NCT04648046
- **Lead sponsor:** Steven Deeks
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04648046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04648046, "CAR-T Cells for HIV Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04648046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*